Sign in
Taking people in United StatesNo phase

Under-mattress monitor to guide mouthpiece adjustment for obstructive sleep apnea

Tests a bed monitor for adjusting a jaw-moving mouthpiece in adults with obstructive sleep apnea.

Key facts

Who runs it
Isabel Moreno Hay
Where
Lexington, United StatesSee the site
Trial code
Registry title
Home-based Under Mattress Monitor for OSA
Status
Recruiting
People taking part
70 people, planned
Started
7 Jan 2026
Expected to end
Mar 2027
Type of study
Interventional
Treatments tested
  • Under-mattress monitor
  • level 3 Home Sleep Apnea Test
  • Mandibular Advancement Device (MAD)
Record updated
3 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obstructive sleep apnea who will use a mandibular advancement device (MAD), a mouth guard that moves the lower jaw forward. It tests an under-mattress monitor that helps adjust the device.

Age
18 Years to 80 Years
Sex
All
Disease stage
Obstructive sleep apnea confirmed by a sleep study (PSG or HSAT) scored by a sleep doctor using the 2017 American Academy of Sleep Medicine rules.
Earlier treatment
People cannot use PAP therapy (a breathing machine) at the same time.

Main reasons for not taking part

  • Central or mixed sleep apnea, or other sleep disorders such as narcolepsy, restless leg syndrome or REM sleep behavior disorder.
  • Neurocognitive disease (a disease affecting memory and thinking).
  • Allergy to the device material (Polyamide 12).
  • Active tooth decay, poorly fitting fillings or crowns, or weak tooth roots.
  • Not able to put in or take out the device, not able to tolerate digital dental impressions, or limited English.

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of Obstructive Sleep Apnea demonstrated with a sleep study polysomnography or home sleep study (PSG or HSAT), manually scored by a sleep physician according to the 2017 American Academy of Sleep medicine scoring guidelines
  • Willingness to commute to the OFP clinic every 2 weeks during MAD titration period
  • Consent to partake in the study

Who cannot take part

  • Concomitant therapy with PAP therapy
  • Patients with concomitant diagnosed sleep disorders, including narcolepsy, restless leg syndrome, rapid eye movement sleep behavior disorder)
  • Neurocognitive disease
  • Allergic to the appliance material (Polyamide 12)
  • Diagnosis of central or mixed sleep apnea
  • Presence of active dental decay, ill-fitting dental restorations, or crown to root ratio unfavorable
  • Inadequate English language comprehension
  • Lack of coordination or dexterity to insert/remove the MAD intraorally
  • Inability to tolerate digital dental impressions

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial is currently available in United States.

  • University of KentuckyLexington, United StatesContact: Sumia Alyousef, BDSTaking people

About the trial

What the trial wants to find out

The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's satisfaction with MAD. A third aim is to analyze if there are differences between the sleep parameters recorded by the under-mattress monitor between responders and non-responders to MAD therapy.

The group in the trial

  • Panthera DSAD mandibular advancement device usersTreatment being tested

    Participants of the study that have been referred to the Orofacial Pain Clinic by their sleep physician for the management of their obstructive sleep apnea with a mandibular advancement device.

    Treatment: Under-mattress monitor, level 3 Home Sleep Apnea Test, and Mandibular Advancement Device (MAD)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Home-Based Under-Mattress Monitoring Device to Estimate Mandibular Advancement in Oral Appliance Therapy for Obstructive Sleep Apnea
Plain-language title
Under-mattress monitor to guide mouthpiece adjustment for obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07186725, who can take part
Record updated
3 February 2026